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Introduction 
 
Since colonization began, Latin America has provided 
cheap labor and natural resources for economically 
dominant countries outside the region. Indeed, the 
existent class and political systems of Latin America are 
built upon the colonialism that exploited these 
resources. Free access and uncontrolled exploitation of 
flora, fauna, mineral and water resources have 
remained critical to the perceived economic interests of 
Latin American countries. 
 
During the last decades, however, a biodiversity 
conservation movement has swept Latin America--and 
the rest of the world.  Increasingly, countries like Brazil, 
Costa Rica, Colombia, and Mexico have become aware 
of the economic interests Northern countries have in 
their biodiversity.  Some countries, like Bolivia, 
Ecuador, and Peru had already benefited from debt-for-
nature swaps, but the “green funds” that were being 
transferred from non-governmental organizations 
(NGOs) in the First World to NGOs within their Latin 
American borders defied governmental controls and led 
to suspicions that environmentalism was only a cover 
for foreign takeover of national lands and resources. 
Thus, biodiversity and environmental interests 
generally have been viewed with suspicion, or even as 
threats to national sovereignty. 
 
  
Meanwhile, corporate interest in new products and 
genetic materials found in the components of biological 
diversity has led to a proliferation of “biodiversity 
prospecting”, which may be defined as the search for 
commercially valuable genetic and biochemical 
resources, with particular reference to the 
pharmaceutical, biotechnological and agricultural 
industries (Reid et al, 1993; Joyce, 1994; Chadwick & 
Marsh, 1994; Posey, 1995; Posey & Dutfield 1996).  
Table 1 gives a summary of past and present 
contributions of biodiversity-rich countries to 
humanity. It gives an indication of the tremendous 
value extracted over the years from tropical natural 
resources and indigenous knowledge, and suggests the 
possibility that many more valuable resources may also 
exist. Indeed, frequently cited figures indicating 
enormous market potential, such as US$ 43 billion per 
year for sales of natural-product based pharmaceuticals 
(Principe, 1989), US$ 50 billion per year for seeds 
derived from traditional crop varieties (RAFI, 1994: 19), 
and similar figures for other natural compounds, led 
Latin American countries to reconsider their attitudes 
toward the value of their flora, fauna, and natural 
resources.  It seemed that the traditional governmental 
policies that provoked the unbridled environmental 
devastation of tropical ecosystems might, after all, be 
contrary to national interests for long term economic 
growth built upon biotechnology.  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 1: Examples of the past and present 
contribution of biodiversity-rich countries to 
humanity 
 
Pharmacy Industry Agriculture and 
food 
Anti-cancer drugs: 
the vinca alkaloids 
Tranquilizers and 
heart drugs: 
reserpine 
Birth control: 
Dioscorea (source 
of many steroidal 
drugs) 
Anaesthetic and 
surgical aids: 
cocaine, 
teterodoxin, d-
tubocurarine, 
picrotoxin, 
madecassol, gum 
“Wild” relatives of 
plantation and 
other species for 
“improvement”/ 
protection 
Exudates: latexes, 
waxes, resins, 
tannins, dyes, 
insecticides (neem, 
pyrethrins, 
rotenone) 
Fibres and canes: 
rattan, bamboos, 
jute, sisal, kapok 
Edible and 
industrial oils: 
“Wild” relatives of 
crops for 
“improvement”/ 
protection 
Beverages, sugar, 
natural sweeteners: 
coffee, tea, cocoa, 
sugar cane, 
thaumatin 
Beans 
Roots and tubers: 
cassava, yam, 
sweet potato 
Fruits and 
Vegetables: tomato, 
  
gutta percha 
Ophthalmology 
and neurology: 
physostigmine, 
pilocarpine, 
atropine, hyoscine 
Respiratory 
disorders: 
emetine, tolu 
balsam, benzoin 
tincture, l-dopa, 
sarsapogenine, 
catechin, camphor  
palm oils, castor 
oil 
Essential oils: 
sandalwood, 
ylang ylang, 
sassafras, 
camphor, anise, 
nutmeg, vanilla, 
cinnamon, clove, 
patchouli, cassia 
Energy 
plants/biomass 
conversion: 
biomethanation, 
fermentation to 
produce ethanol, 
pyrolysis 
avocado, sweet 
pepper, aubergine, 
cucumber, 
breadfruit, okra 
Spices: cloves, 
nutmeg, black 
pepper, allspice, 
cardamom, vanilla, 
cinnamon 
Nuts: brazil, 
peanut, cashew, 
kola, sesame, 
macadamia 
Animals: chickens, 
wild pigs, water 
buffalo 
 
Dutfield, 1993 (Based on information in Friends of the 
Earth, 1992). 
 
 
 
 
Furthermore, industry was not only interested in 
genetic resources, but also in traditional knowledge 
held by local communities on the utilization of flora and 
fauna (Gray, 1991; RAFI, 1994; Chadwick & Marsh, 
1994; Posey & Dutfield, 1996; Balick et al, 1996). 
 
It is well documented that throughout the history of 
Latin America, indigenous and traditional peoples 
(campesinos, caboclos, peons, colonos, caicaras, etc) 
have been treated--at best--with disdain by the ruling 
elite (Wolf & Hansen, 1972; Wolf, 1982).  It was not 
until the 17th Century that “Indios” were even 
considered to be humans with souls; and most Western 
scientists still believe traditional knowledge is mere 
  
folklore and, therefore, not scientific.  In short, these 
“backward and primitive” peoples are seen as barriers 
to development, learning and civilization.  Armed with 
those assumptions, governments--and even scientists 
and environmentalists--have found it easy to justify the 
dispossession of Indians and peasants from their land 
and resources in the name of development, 
conservation, and progress.1  
 
It is not surprising, therefore, that Latin American 
countries find it difficult to respond to the political and 
economic problems raised by the global biodiversity 
debate. In short, how can 500 years of policy to 
systematically “tame” and “civilize” (euphemisms for 
“destroy”) the environment and indigenous and 
traditional communities be reversed in time to protect 
flora, fauna and the peoples who know the “secrets” to 
these new sources of national wealth? In other words: 
how can environment and biodiversity--until recently 
considered subversive concepts--be embraced without 
undermining the power of the old land-based 
oligarchies and extractive industries whose survival 
depends on cheap natural and human resources?  
 
As Latin American countries struggle with these 
questions, biodiversity prospectors invade the most 
remote corners of jungles, mountains, and coastal reefs-
gleaning from they consider to be the public domain 
everything they can before national legislation can 
regulate access and transfer of genetic resources and 
traditional knowledge.  By the time most Latin 
                                      
1 A publication of the World Rainforest Movement (Colchester & 
Watson, 1995) documents how the indigenous situation has 
rapidly deteriorated in Venezuela. Similarly, announcements in 
Brazil indicate that the Congress is about to “re-study” the 
existing indigenous reserves: an euphemism for reducing 
indigenous lands and territories to even smaller portions of the 
country than now exist. 
  
American countries do get around to legislating on 
genetic resources and traditional knowledge, the more 
aspirant and persistent bioprospectors may feel they 
will have all they need for the development of new 
products for a long time to come. “What’s a poor 
country (as most Latin American countries claim they 
are), that suddenly realizes it is rich in biological and 
cultural diversity to do?”  This question is central to the 
entire philosophy and political processes behind the 
Convention on Biological Diversity. 
 
 
The convention on biological diversity and 
Intellectual property rights (IPRs) 
 
The Convention on Biological Diversity (CBD) was 
opened for signature during the United Nations 
Conference on Conservation and Development 
(UNCED) in Rio de Janeiro in 1992.  While the CBD has 
been welcomed by many indigenous peoples, they are 
nonetheless concerned that in practice it may turn out 
to represent a sovereignty grab by nation states over all 
biological and ecological resources including their own. 
This is despite the lofty Objectives proclaimed in Article 
1: 
 
[...] the conservation of biological diversity, the sustainable 
use of its components and the fair and equitable sharing of 
the benefits arising out of the utilization of genetic 
resources, including by appropriate access to genetic 
resources and by appropriate transfer of relevant 
technologies, taking into account all rights over those 
resources and technologies, and by appropriate funding. 
 
While states have sovereign rights over resources, there 
is no mention of any rights that indigenous peoples 
might have. Similarly the beneficiaries of equitable 
sharing are apparently the contracting parties (i.e. the 
governments that ratify the CBD), not individuals or 
communities.  
  
 
It is important to note, however, that “relevant 
technologies” can be interpreted to mean “indigenous 
and traditional technologies” (in reference to the 
language of Article 18.4 in the “Access to and Transfer 
of Technology” Section), or those based upon 
traditional “knowledge, innovations and practices”. 
Indeed, Article 8.j contains some interesting language. 
It states that each contracting party “subject to national 
legislation” shall: 
 
[...] respect, preserve and maintain knowledge, innovations 
and practices of indigenous and local communities 
embodying traditional lifestyles relevant for the 
conservation and sustainable use of biological diversity and 
promote the wider application with the approval and 
involvement of the holders of such knowledge, innovations 
and practices and encourage the equitable sharing of the 
benefits arising from the utilization of such knowledge, 
innovations and practices. 
 
Unfortunately, these “commitments” are vague and do 
not seem to legally require governments to do anything. 
So while indigenous peoples might be flattered with the 
recognition of their relevance to in situ conservation, 
they are hardly convinced that the governments that 
have tried so hard to destroy them and their habitats 
are now suddenly going to zealously defend their rights.  
They are also not convinced that—given their disastrous 
experiences in the past--any “equitable sharing” will 
ever trickle down to the source of both the knowledge 
and resource, i.e., their communities. Indigenous 
leaders are both frustrated and angry that while 
Amazonian countries do little to protect their interests 
or guarantee even their most basic rights, they are 
nonetheless now anxious to claim sovereignty over even 
local knowledge systems. 
 
And how would this protection of indigenous 
knowledge take place anyway? Intellectual property 
  
rights (IPRs) are implicitly assumed by the CBD to be 
the principal mechanisms to provide “equitable 
sharing”. But IPRs are problematic for indigenous 
peoples for the following reasons: 
 
(i) they are founded upon a conception of individual 
authorship that does not suit community innovation. 
Indigenous knowledge may, for example, be attributed 
to ancestor spirits, vision quests, or lineage groups, but 
rarely to individuals. A group of lawyers, academics and 
activists summed up the situation in a document known 
as the Bellagio Declaration:2 
 
Contemporary intellectual property law is constructed 
around the notion of the author as an individual, solitary 
and original creator, and it is for this figure that its 
protections are reserved. Those who do not fit this model--
custodians of tribal culture and medical knowledge, 
collectives practising traditional artistic and musical forms, 
or peasant cultivators of valuable seed varieties, for 
example--are denied intellectual property protection. 
 
(ii) they are intended to benefit society through the 
granting of exclusive rights to individuals and juridical 
persons (i.e. corporate entities). Indigenous peoples and 
local communities do not usually have a legal 
personality and cannot easily claim legal rights as a 
group.  
 
(iii) they cannot easily protect information not resulting 
from a specific historic act of “discovery”. Most 
indigenous knowledge is transgenerational, 
communally shared, and is usually considered to be in 
the public domain, and therefore unprotectable.  
 
                                      
2 In: Boyle, J. 1996 Shamans, Software and Spleens: Law and 
the Construction of the Information Society, Cambridge: 
Harvard University Press. Pp. 192-200. 
  
(iv)  they are likely to conflict with customary systems of 
ownership, tenure, and access.  
 
(v) they help owners to capture the market value of 
knowledge, but fail to reflect spiritual, aesthetic, or 
cultural -- or even local economic – values (see Posey, 
1999). Information or objects may have their greatest 
value to indigenous peoples because of their ties with 
cultural identity and symbolic unity, not because money 
can be made from selling them. In fact, indigenous 
peoples may be concerned primarily to prevent 
commercialisation and to restrict use and distribution. 
As a 1994 COICA (Coordinating Group of the 
Indigenous Peoples of the Amazon Basin) statement 
puts it: 
 
For members of indigenous peoples, knowledge and 
determination of the use of resources are collective and 
inter-generational. No indigenous population, whether of 
individuals or communities, nor the government, can sell or 
transfer ownership of resources which are the property of 
the people and which each generation has an obligation to 
safeguard for the next. 
 
(vi) they are subject to manipulation by economic 
interests that wield the most political power. So while 
sui generis protection has been obtained for, say, 
semiconductor chips, indigenous peoples lack the legal 
means for protecting even their most sacred plants, 
places, songs, art, or artefacts. 
 
(vii) most IPRs (especially patents) are expensive, 
complicated, and time-consuming to obtain, and even 
more difficult to defend. 
 
There are good reasons why indigenous peoples are 
worried that intellectual property rights not only fail to 
protect their knowledge and resources but actually 
encourage theft and other violations of their basic 
rights. Take for example, the three patent applications 
  
that were made for human cell lines developed from 
blood “donated” by indigenous peoples, including one 
from a member of a recently-contacted group of hunter-
cultivators in New Guinea, another from the Solomon 
Islands, and a third from the Guaymi Indians of 
Panama (Posey & Dutfield, 1996: 25-27). The patent 
applicant in each case is the US National Institutes of 
Health, with the government scientists involved in the 
project named as inventors. 
 
Another recent case of alleged biopiracy has led to 
something of a diplomatic scandal between Guyana and 
Great Britain. A British chemist, Conrad Gorinsky, is 
being sued in a British court over his patenting, without 
permission of either the country nor the Wapishana 
Indians who provided him information, a nut called 
tipir that stops hemorrhages, prevents infections, and is 
used as a contraceptive.  
 
In fact, this is the second such patent held by Gorinsky.  
The other is on the Greenheart tree (Ocotea rodiaei), 
which produces tipir. According to his description, the 
active ingredient of the plant is an efficient antipyretic, 
capable of treating malaria, tumours and even the AIDS 
virus. Gorinsky names the substance rupununine, a 
reference to the region's main river. The other active 
ingredient registered by the chemist, polyacetylene, was 
obtained from the Cunani bush (Clibadium sylvestre). 
It is prescribed as a powerful stimulant of the central 
nervous system, as a neuromuscular agent capable of 
reverting cases of heart blockage. 
 
Since these plants are also found in Brazil and used by 
indigenous peoples there, the Wapishana chiefs have 
appealed to Senadora Marina da Silva to prevent the 
recognition of Gorinsky’s patents in Brazil.  An ISTOÉ 
(Villamea & Pinto 2000) article reports that “At least 
one institution has already responded to this appeal: 
the Brazilian Bar Association (OAB), which was 
  
represented by an environmental law specialist, who 
affirms that ‘This is a model case, because Gorinsky has 
stated  in the text of both patents that the Wapishanas 
used those plants’”. 
 
Gorinsky, according the ISTOÉ article, insisted that 
rupununines and polyacetylenes are his discoveries. "I 
have dedicated my life to this work. I have registered 
specific components that had not been decoded. I have 
made all the intellectual effort, and spent thousands of 
dollars from my own pocket. Would the Indians ever 
invest in this?" reacted the scientist, highlighting that 
the substances have not yet been marketed. "But no one 
can take a patent away from the inventor. We can't talk 
about how to share the pie if there's no pie," added 
Gorinsky (ibid.). 
 
This is an interesting case for several reasons, not the 
least of which being that the legal proceedings were 
begun by the indigenous leaders from two different 
Latin American countries. Indigenous peoples in Latin 
America became acutely aware of how their plants were 
being patented when ayahuasca, a sacred, dream-
inducing medicinal drink commonly used by 
Amazonian Peoples of Ecuador, Colombia, Peru and 
Brazil, was patented by a US scientist/entrepreneur. At 
the request of indigenous peoples from Ecuador and 
Colombia—and supported by incredible world-wide 
pressure--the United States Patents Office revoked the 
ayahuasca patent in November 1999. 
 
A recent “international indigenous assembly” was 
convened in Roraima to discuss the case.  A declaration 
of “repudiation” was proclaimed as a result.  
 
In another strange case, a US-based company, POD-
NERS, L.L.C, is suing Mexican bean exporters, charging 
that the Mexican beans (Phaseolus vulgaris) they are 
selling in the US infringe POD-NERS' US patent on a 
  
yellow-colored bean variety. It's not surprising that the 
Mexican beans are strikingly similar to POD-NER's 
patented bean. That's because POD-NERS proprietary 
bean, "Enola" originates from the highly popular 
"Azufrado" or "Mayocoba" bean seeds the company's 
president acquired from Mexican peasant farmers in 
1994. The Mexican yellow beans have been grown in 
Mexico for centuries, developed by generations of 
Mexican farmers and more recently by Mexican plant 
breeders. 
 
These examples illustrate why indigenous communities 
are less than enthusiastic about and trustful of 
scientists. They also explain why patents (the focus of 
IPR debates) have become a new war-cry for 
indigenous rights.   
 
In a now famous declaration from a UNDP (the United 
Nations Development Programme) Consultation on the 
Protection and Conservation of Indigenous Knowledge 
organized by indigenous groups from Boliva and COICA 
at Santa Cruz de la Sierra in September, 1994, 
indigenous leaders declared a moratorium on all 
research and  bioprospecting until appropriate 
protection measures are in place.3  The threat of a 
moratorium is unnerving, since scientists and research 
institutions are increasingly dependent upon the private 
sector for their livelihoods. This means the fruits of 
their labors are subject to commercial exploitation, or 
indeed, are now designed for that purpose (Posey, 
1995). It is often hard for scientists themselves to know 
when they must wear the hat of their patrons versus the 
mantle of their scientific discipline.  From the 
indigenous perspective, they (we) are all the same.  This 
means that negotiating access by scientists to 
                                      
3 The Statement is printed as Appendix 10, pp 219-222, in Posey 
& Dutfield, 1996. 
  
indigenous and local communities--whether for 
bioprospecting or scientific purposes--may take 
considerable time and energy and has become a 
profoundly political act (Posey, Dutfield & Plenderleith,  
1995).4  
 
As eminent scientists, such as Drs. Brent and Elois Ann 
Berlin have found after years of work in Chiapas, 
Mexico, a paranoia has struck indigenous groups 
worldwide. This makes negotiating such things as “prior 
informed consent” and “benefit-sharing” one of the 
most challenging aspects of research with local peoples.  
It is difficult to carry out research—however beneficial it 
may be to the local communities and the nations—in 
climates of mistrust, mis- (or dis-) information, and 
lack of national laws. 
 
The private sector and scientific interests are eager that 
the CBD resolve these dilemmas to become an 
international vehicle for clarifying the terms of access 
and transfer of genetic resources and appropriate 
technologies. Indeed, the CBD has advanced 
considerably towards the development of guidelines 
and principles for sui generis options to existing IPRs. 
The Third Conference of the Parties (COP III) of the 
CBD, held in Buenos Aires in 1996, discussed Article 8.j 
and Intellectual Property Rights and agreed to “develop 
national legislation and corresponding strategies for the 
implementation of Article 8.j in consultation with 
representatives of their indigenous and local 
communities” (Decision III/14).  An inter-sessional 
Workshop on Traditional Knowledge and Biodiversity 
                                      
4 Significantly, some indigenous groups already have their own 
policies and regulations addressing the need to control access to 
their territories, to monitor the activities of plant collectors and 
researchers, and to become beneficiaries of plant collections and 
research. Examples in Latin America are the Kuna of Panama 
and the Awa of Ecuador (see Posey & Dutfield, 1996). 
  
was held in Madrid in November, 1997, and proposed to 
COP-IV that a “participatory mechanism” be 
established to review legal elements related to benefit-
sharing and traditional cultural practices for 
conservation and sustainable use. COP-IV (Decision 
IV/8) agreed to establish a ”regionally balanced panel of 
experts” to develop a “common understanding of basic 
concepts and to explore all options for access and 
benefit sharing on mutually agreed terms including 
principles, guidelines, and codes of best practices for 
access and benefit sharing arrangements”. Decision 
IV/9 on Implementation of Article 8(j) and Related 
Provisions specifically recognized the “importance of 
making intellectual property-related provisions of the 
Convention on Biological Diversity and provisions of 
international agreements relating to intellectual 
property mutually supportive, and the desirability of 
undertaking further cooperation and consultation with 
the World Intellectual Property Organization”. The 
decision also agreed to establish an “ad hoc open-ended 
inter-sessional working group” to address IPR and 
issues related to Article 8.j (Dutfield, 2000).   
 
Whatever the CBD recommends, however, it is 
important to remember that states themselves are 
responsible for adequate national legislation to govern 
access to and transfer and use of their genetic resources 
and traditional technologies within their sovereign 
boundaries. The following section looks at some efforts 
by Latin American countries.  
 
 
 
National and regional initiatives  
 
A number of initiatives are underway in Latin American 
countries to find adequate protection of genetic 
resources and knowledge.  The overall goal is to find 
legal ways of sustainably exploiting biodiversity in a 
  
commercial, yet equitable manner. Most of what is 
happening has been guided by: 
 
 
1.  Costa Rica 
 
Costa Rica has led the way in Latin America (and 
beyond) on issues of access and transfer legislation, 
equitable benefit-sharing, and protection of genetic 
resources.  Perhaps the best know example of “equitable 
arrangements” is the Merck-INBio agreement from the 
early 1980’s. The National Biodiversity (INBio), an 
NGO closely linked with the government, was 
established to carry out a species inventory of the 
country and to explore the commercial potential of 
biological resources with corporations through Material 
Transfer Agreements (MTAs). According to Costa Rican 
law, the biological diversity of the country on public and 
private lands is national patrimony and the State has 
the exclusive right to grant permits to organizations 
such as INBio to investigate, collect and exploit the 
country’s biological resources within its Conservation 
Areas.5  
 
The agreement between Merck and INBio provides the 
latter with an advanced payment of $1 million and 
royalties in case a product is derived from any of the 
extracts, which INBio will transfer to Merck. 50% of the 
royalties are to be forwarded to the government’s 
National Parks Fund.  
 
There were several problems with this initial approach: 
 
i) The government claims sovereignty over the country’s 
biodiversity and did not recognize the territorial and 
                                      
5 For greater detail, see Posey & Dutfield, 1996. 
  
resources rights of indigenous peoples and local 
communities. 
 
ii) INBio secured prospecting rights to lands, which 
according to national laws are under State ownership, 
permitting very little in the way of local control. In fact, 
the Director of INBio was unaware that there were 
indigenous peoples in the country--although the 
agreement was for collecting on national lands, 
including those of eight indigenous peoples.  
 
iii) Although the agreement with Merck provided 
benefits for the government and for INBio, few benefits 
went to local communities except for the training of a 
small number of “para-taxonomists”. Furthermore, 
INBio will not contribute at all to revitalising local 
knowledge traditions because it professes to have no 
interest at all in such knowledge. 
 
iv) Although the advance payment by Merck seemed 
substantial at the time, it was hardly generous; neither 
was the agreed royalty percentage of between 3-4%. 
 
v) There is no provision in the agreement for co-
ownership of patents (Joyce, 1994: 126-127). Therefore, 
Merck retained exclusive intellectual property rights. 
 
Since this historic agreement, INBio has made 
numerous other agreements with Merck and other 
pharmaceutical and natural product companies that 
have confronted some of these basic problems (Mateo, 
1998).  The Merck-INBio experience was instrumental 
in development of Costa Rica’s new (April, 1998) Ley de 
Biodiversidad, which has become one of the “most 
ambitions and elaborate national laws” for Latin 
America (Dutfield, 2000).   
 
The Ley de Biodiversidad seeks to implement the 
provisions of the CBD and to develop  “a sui generis 
  
system to protect the intellectual rights of indigenous 
peoples and local communities” (ibid).  There are 13 
overall objectives of the Ley, summarised below, and 
have been influential in guiding legislative activities in 
Latin American countries (as well as others around the 
world) attempting to control the loss of genetic and 
knowledge  resources. 
                                             
  
                                           
Principles and objectives of the Ley de 
Biodiversidad  
(Costa Rica, 1998) 
 
General principles 
 
1. Respect for all forms of life – all living things have the 
right to life independent of their actual or potential value. 
2. The elements of biodiversity are meritorious – they have 
decisive and strategic importance for the country’s 
development and are essential for the domestic, social, 
cultural and aesthetic use of its inhabitants. 
3. Respect for cultural diversity – the diversity of cultural 
practices and associated knowledge of biodiversity 
elements must be respected and promoted, in conformity 
with national and international juridical standards, 
particularly in the case of peasant communities, 
indigenous peoples and other cultural groups. 
4. Intra- and inter-generational equity – the State and 
private individuals will ensure that biodiversity elements 
are utilised sustainably in such a way that the possibilities 
and opportunities from their use and the benefits are 
guaranteed in a just manner for all sectors of society and 
to satisfy the needs of future generations. 
 
Objectives (selected) 
 
1. To integrate conservation and sustainable use of 
biodiversity element into the development of socio-
cultural, economic and environmental policies. 
2. To promote active participation of all social sectors in 
conservation and ecologically sustainable use of 
biodiversity, in pursuit of social, economic and cultural 
sustainability. 
3. To regulate access and facilitate equitable distribution of 
social, environmental and economic benefits for all sectors 
of society, with special attention to local communities and 
indigenous peoples. 
4. To recognise and compensate the knowledge, innovations 
and practices of indigenous peoples and local communities 
for conservation and ecologically sustainable use of 
biodiversity elements. 
5. To recognise rights arising from the contribution of 
scientific knowledge for conservation and ecologically 
  
sustainable use of biodiversity elements. 
6. To promote access to biodiversity elements of biodiversity 
and technology transfer. 
7. To foster international and regional cooperation to achieve 
conservation, ecologically sustainable use and distribution 
of benefits derived from biodiversity, especially in frontier 
areas or  shared resources. 
 
From: G. Dutfield, 2000:111 
 
2. The Andean Community 
 
Some Latin American countries, for example the 
Andean Community countries, have responded with 
draft legislation intended to establish equitable terms 
for granting access to genetic resources and sharing 
benefits with indigenous peoples. The Andean 
Community Common System on Access to Genetic 
Resources was adopted by member states (Bolivia, 
Colombia, Ecuador, Peru and Venezuela) in 1996.  
 
The basic terms of the Common System include: 
 
 i) sharing of benefits between receivers of biological 
resources, member’s states and providers, which may 
be legal entities, private individuals, or indigenous or 
local communities;  
 
ii) restrictions on transfer to third parties;  
 
iii) reporting on obligations on future uses;  
 
iv) obligations related to intellectual property;  
 
v) exclusivity and confidentiality;  
 
vi) recognition of the Member States or provider in the 
publication of research results.  
 
  
Member States recognize the rights of indigenous and 
local communities over their knowledge, innovations 
and practices, and would concede to local communities 
the “authority to decide whether and how to share such 
knowledge, innovations and practices”. 
 
Andean Community countries ascribe biodiversity to 
the national patrimony. However, it is unclear if States 
(governments) have the exclusive rights to determine 
access and set terms for transfer and benefit-sharing. It 
is equally unclear what authority local, state and 
regional governments have vis a vis national or federal 
governments.  In the absence of clear laws on genetic 
resources, most countries find they are incapable of 
limiting access or even monitoring activities within 
their borders.   
 
One very significant aspect of the Andean Common 
System on Access to Genetic Resources is that 
protection is extended to derivatives, which are defined 
as “a molecule or combination of mixture of natural 
molecules, including raw extracts of living or dead 
organisms of biological origin, derived from the 
metabolism of living organisms” (Dutfield, 2000).  
Although this does not cover synthetic products 
developed from artificial processes using genetic 
information or molecules, it does claim ownership over 
compounds that are isolated from nature, even if the 
laboratory work is done outside the Andean countries. 
 
The Common System also recognizes “intangible 
components”, such as “knowledge, innovations, and 
practices” (individual or collective) that are of actual or 
potential value. These components--and their 
derivatives--are also protected and regulated by 
national laws, which require legally recognized licenses 
and contracts registered with the “Competent National 
Authority”.  Any and all products, patents or claims that 
  
do not have such a license are not protectable nor 
recognized by Andean countries. 
 
In addition to the Common System, some Andean 
countries are attempting to protecting indigenous 
knowledge though existing legal measures.  For 
example, an experimental project based in Ecuador and 
supported by the InterAmerican Development Bank is 
trying to protect such knowledge under trade secrecy 
law (Dutfield, 2002; Vogel, 1997). An NGO called 
Ecociencia is documenting the botanical knowledge of 
the participating indigenous groups, and registering it 
in closed-access databases. Checks are made to see 
whether each entry is not already in the public domain 
and whether other communities have the same 
knowledge. If an entry is not in the public domain, the 
community or communities with the knowledge have a 
trade secret. The trade secret can then be disclosed to 
companies with benefit sharing guaranteed by a 
standardized contract. These benefits can then be 
distributed among the trade secret-holding 
communities and the Ecuadorian government. To date, 
the database contains 8,000 entries provided by six 
participating indigenous groups. Sixty percent of the 
uses appear so far not to have been disclosed through 
publications. Already, three companies have expressed 
interest in accessing the database.6 In Peru, the 
Aguaruna people have utilized know-how protection 
to successfully license their traditional knowledge for 
the use of genetic resources by an International 
Cooperative Biodiversity Group Program (ICBG) project 
with Washington University (USA), two Peruvian 
Universities and Searle & Co. pharmaceuticals, which is 
part of Monsanto (Tobin, 1996).  
                                     
 
 
6 Information provided by Dr Rocio Alarcon of Ecociencia in 
seminar at Oxford University, 7 Feb. 2001. 
  
 
3.  Brazil 
 
Concern over biopiracy is, as the Brazilian anthropologist 
Alcida Ramos explains (Ramos, 2000), “a rare case in 
which national and indigenous interests converge”. 
Official reactions against the unauthorized “poaching” of 
genetic resource and indigneous knowledge, “have 
reinforced the indigenous sense of indignation” (ibid). 
 
Brazil and other nations have vehemently protested 
against biopiracy and have taken events such as the 1992 
Rio Summit as opportunities to elicit more equitable 
commitments from the northern nations.  One of the 
first and most historic Latin American attempts to 
implement the objectives of Article 8.j of the CBD 
occurred in Brazil with Proposed Law (PL 2057/91).  
The proposal was approved in 1994 by the Chamber of 
Deputies of the national legislature, but has never 
passed into the Senate and is still under consideration 
for its constitutionality. The proposed law is intended to 
protect and assure respect for indigenous peoples’ social 
organization, customs, languages, beliefs and traditions, 
and rights over their territories and possessions.  
 
Articles 18-29 deal with the intellectual property of 
indigenous peoples. Among the important provisions of 
potential benefit to indigenous peoples are the 
following: 
  
- the right to maintain the secrecy of traditional 
knowledge;  
 
- the right to refuse access to traditional 
knowledge;  
 
- the right to apply for IPR protection, which, in the 
case of   collective knowledge will be granted in the 
name of the community or society;  
  
 
- the right of prior informed consent (to be given in 
writing) for access to, use of and application of 
traditional knowledge;  
 
- the right to co-ownership of research data, 
patents and products derived from the research but 
without the community having to pay patent fees;  
 
- and, the right of communities to nullify patents 
illegally derived from their knowledge. 
 
The Act would redefine patents and copyright by 
allowing community IPR to continue without time limit. 
 
There is little surprise that such a revolutionary bill 
would have run into troubles in the Brazilian Congress, 
especially given the heavy and unrelenting pressures 
from industrial countries to implement a standard (U.S. 
style) IPR regime.  Brazil has had patent law since 1887 
and established a National Institute for Industrial 
Property (INPI) in 1971 to administer its “modern” 
Industrial Property Code (Law 5772/71).  This law was 
replaced in May, 1997, by Law 9297 that “streamlines” 
industrial property protection and strengthens patents 
for industrial property7.  There is no mention of 
collective property, community resources, or traditional 
technologies of indigenous and local peoples in the 
revised law. 
 
During the past few years, however, Senadora Marina 
da Silva of Acre has sponsored public hearings 
throughout Brazil on legislation governing access to 
genetic resources. These hearing have led to a greater 
                                      
7 A critique of this law and other implementing mechanisms 
(regulatory acts), as well as complete texts of the law in English, 
French and Portuguese, can be found on the INPI Web Site:  
http://www.inpi.gov.br//. 
  
public understanding of “biopiracy” and 
“bioprospection”—and, along with it, a growing concern 
about how Brazil, and more specifically, Brazilians are 
being “ripped off”. The Senadora’s findings have been 
encompassed in Lei 306/95 governing “Acesso aos 
Recursos Biologicos e Geneticos”, which was approved 
by the Senate in June, 1998, is still being debated by the 
House of Deputies.  There is a proposal by the Casa 
Civil to remove reference to community and property 
rights for indigenous and traditional communities, 
again, it is claimed, so as not to conflict with existing 
industrial property legislation8. 
 
Under the Brazilian Constitution of 1988, federal States 
were granted greater autonomy in the Federal Union. 
The State of Acre, tired of awaiting national action, 
enacted its own Lei de Accesso aos Recursos Geneticos 
(Projeto de Lei No 15/97) in 1997.  The law draws upon 
the Andean Common System and the PL 2057/91. It 
recognizes the collective rights of indigenous and local 
peoples over their genetic resources and traditional 
knowledge.  It also regulates collection of genetic 
materials for “research, bioprospecting, conservation, 
industrial application, commercial use, and other 
purposes” and requires equitable and adequate benefit-
sharing from such materials and collections.  The 
Secretaria de Estado de Ciencia, Tecnologia e Meio 
Ambiente (SECTMA) do Acre becomes the body 
responsible for licensing, monitoring, and initiation of 
legal action, since one of the most interesting and 
historical aspects of the Lei is that infringements of the 
law carry criminal penalties.  
 
In November, 1997,  Deputada Socorro Gomes (Para) 
presided over the Commissao Externa Criada para 
Apurar Denuncias de Exploracao e Comercializacao 
                                      
8 Personal communication, David Hathaway, 14 July, 1998. 
  
Ilegal de Plantas e Material Genetico na Amazonia, 
which reports to a special Commissao de Biopirararia.  
The report calls for more rigorous laws to control 
“Biopiracy”, including expanded criminal charges for 
unauthorised collection, exploitation, and use of genetic 
resources and traditional knowledge about them. 
 
As a result, in 1998, three Swiss scientists were arrested 
for attempting to transport medicinal plant samples out 
of Acre without the appropriate authorizations.  In 
2000, similar arrests were carried out at the Manaus 
airport when German arachnologists tried to smuggle 
specimens out of Brazil. 
 
The idea that genetic resources and traditional 
ecological knowledge are valuable resources that must 
be protected is indeed a major change in the history of 
Brazil—and, indeed, of Latin America. Until very 
recently it would have been inconceivable that a 
Congressional Commission would be established to 
investigate illegal exploitation of plants or animals, let 
alone, traditional knowledge. It seems that times have 
indeed changed! 
 
 
Conclusions 
 
The political legacy in Latin America of ruthless 
exploitation of natural resources leading to ecological 
destruction--and the systematic annihilation and 
marginalization of indigenous, traditional and local 
communities—have left countries unprepared to deal 
with economic and political issues raised by 
globalization of markets and biotechnology based on 
biodiversity developments. Although governments have 
acted to declare sovereign rights over flora, fauna, and 
appropriate technologies for sustainable development 
and biodiversity conservation, legal structures and 
political institutions are inadequate or non-existent to 
  
protect, monitor, or control access and transfer or 
benefit-sharing. 
 
Some recent efforts by Costa Rica, Brazil and the 
Andean Community to establish regimes that control 
access and protect traditional resources  are 
fundamentally radical in that they recognize the 
collective and community-based nature of in situ 
biodiversity conservation - which implies recognition of 
indigenous land, territorial, and resource rights.  These 
rights are sometimes subsumed under the rubric of self-
determination, historically seen by Latin American 
countries as a threat to their national sovereignty.  
However, with the rampant loss of genetic resources 
and traditional knowledge through biodiversity 
prospecting - by national, international, and 
multinational interests - Latin American countries will 
have to forge equitable partnerships with indigenous 
peoples in order to attain local access to knowledge, 
flora and fauna. 
 
The growing political awareness and effective 
international organization of indigenous groups--
combined with the ethical, moral and legal concerns of 
scientists co-opted by commercial concerns--means 
that actions to develop principles and guidelines for 
access, transfer and benefit-sharing will no longer await 
government paralysis. By the time Latin Amazonian 
governments actually do act to protect traditional 
resources, they may find their sovereign rights 
undermined by research moratoria, biopirate “witch-
hunts”, private corporations, government 
entrepreneurs, and extensive data banks of “national 
patrimony” being beamed around the planet on the 
Internet. 
 
It is unclear how globalized biodiversity and 
biotechnology will influence economic development in 
Latin America--but it is certain that “business as usual” 
  
will only lead to increased undermining of national 
sovereignty through unauthorized and uncontrolled 
exploitation of traditional resources. The recent flurry 
of activities, such as Costa Rica’s Projeto de Lei and 
similar efforts may indicate dramatic changes in how 
Latin American countries view their human and genetic 
resources, but it remains to be seen if the economic 
interests and public indignation over “biopiracy” 
translate into practical policies that improve the 
conditions of local, traditional, and indigenous peoples.  
One hopes that when the hype and hysteria is over, 
science, industry and research will be transformed into 
more responsible (and respectful) institutions because 
of the political and economic negotiations now 
necessary with indigenous and local communities. And 
hopefully, indigenous peoples may finally be 
recognized—after more than 500 years of oppression—
as valued citizens who are critical to responsible and 
sustainable development in Latin America. 
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